OTCM
RTON
Market cap890kUSD
Oct 08, Last price
0.03USD
1D
0.00%
1Q
0.67%
IPO
-93.62%
Name
Right On Brands Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Right On Brands, Inc., operating through its subsidiaries, is engaged in the marketing and sale of a broad selection of hemp-enhanced snack foods. The company's product line also encompasses a variety of health and wellness items, including cannabidiol (CBD) supplements such as ENDO Drops for daily use and ENDO gummies, as well as ENDO Ease, a topical pain relief solution. They further offer ENDO Tokes, a pre-rolled CBD flower fashioned as a cigarette, in addition to high alkaline and natural mineral waters. These offerings are distributed to consumers in the hemp marketplace via both online platforms and physical retail locations. Incorporated in 2011, the entity, which was previously known as HealthTalk Live, Inc., adopted its current name, Right On Brands, Inc., in August 2017 and is headquartered in Rowlett, Texas.
Key people
Jerry Grisaffi
Chairman of the Board, Chief Financial Officer · since 2019
George W. Carter
Director · since 2011
Director · since 2020
Ashok Patel
President, Chief Executive Officer, Director · since 2018
A. David Youssefyeh
Director · since 2019
Legal address
C/O CORPORATE ADMINISTRATIVE SERVICES INC
1955 BARING BLVD
Sparks, NV 89434
US
1955 BARING BLVD
Sparks, NV 89434
US
Headquarters
6501 Dalrock Road, Suite 100
Rowlett, TX 75089
US
Rowlett, TX 75089
US
Previous name
HEALTHTALK LIVE, INC.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||